-transparent.png){kind=logo}
We studied 34 MS patients who were treated experimentally by thymectomy with or without 1 year of azathioprine therapy. After 3 years, there was no evidence of benefit. Relapsing-remitting patients had done as well or better clinically than controls, and the chronic progressive group did less well statistically than controls.
Related Publications
J L Trotter, and
D B Clifford, and
E B Montgomery, and
T B Ferguson
May 1998,
European journal of neurology,
J L Trotter, and
D B Clifford, and
E B Montgomery, and
T B Ferguson
March 2021,
Diagnostics (Basel, Switzerland),
J L Trotter, and
D B Clifford, and
E B Montgomery, and
T B Ferguson
February 1997,
Brain : a journal of neurology,
J L Trotter, and
D B Clifford, and
E B Montgomery, and
T B Ferguson
January 2004,
Neuroepidemiology,
J L Trotter, and
D B Clifford, and
E B Montgomery, and
T B Ferguson
September 2018,
Multiple sclerosis (Houndmills, Basingstoke, England),
J L Trotter, and
D B Clifford, and
E B Montgomery, and
T B Ferguson
August 1999,
Multiple sclerosis (Houndmills, Basingstoke, England),
J L Trotter, and
D B Clifford, and
E B Montgomery, and
T B Ferguson
November 2010,
Acta neurologica Scandinavica,
J L Trotter, and
D B Clifford, and
E B Montgomery, and
T B Ferguson
June 2001,
Journal of the neurological sciences,
J L Trotter, and
D B Clifford, and
E B Montgomery, and
T B Ferguson
February 1996,
Italian journal of neurological sciences,
J L Trotter, and
D B Clifford, and
E B Montgomery, and
T B Ferguson
March 2017,
Acta neurologica Belgica,
